Wordt geladen...
Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
Background: Immunotherapy has drastically changed the outlook for melanoma patients over the past decade. Specifically, the dual blockade of immune checkpoints using ipilimumab and nivolumab has shown unprecedented response rates and survival outcomes. This immense achievement, though, is at the cos...
Bewaard in:
| Gepubliceerd in: | Cancers (Basel) |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464656/ https://ncbi.nlm.nih.gov/pubmed/32824780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082329 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|